UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.854

Sortiert nach

A Case of Severe Pneumocystis Pneumonia in an HIV-Negative Patient Successfully Treated with Oral Atovaquone

Infection and drug resistance, 2023-01, Vol.16, p.1561-1566

2023

Volltextzugriff (PDF)

Three-dimensional Magnetohydrodynamic Simulations of Cold Fronts in Magnetically Turbulent ICM

The Astrophysical journal, 2007-07, Vol.663 (2), p.816-823

2007

Volltextzugriff (PDF)

Arginine vasopressin neuronal loss results from autophagy-associated cell death in a mouse model for familial neurohypophysial diabetes insipidus

Cell death & disease, 2014-03, Vol.5 (3), p.e1148-e1148

2014

Volltextzugriff (PDF)

AB0476 Influence of the Reason for Discontinuation of Previous TNF Antagonists on the Retention of Tocilizumab

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1056-1056

2015

Volltextzugriff (PDF)

AB1181 The Impact of Physical Function on Patient Global Assessment in Rheumatoid Arthritis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1297-1298

2015

Volltextzugriff (PDF)

AB0466 The Outcome of Tocilizumab Treatment with Achievement of Glucocorticoids Withdrawal Against Rheumatoid Arthritis for 24 Months from TBC Registry

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1051-1052

2015

Volltextzugriff (PDF)

THU0078 Effects of Concomitant Methotrexate on the Long-Term Outcome of Knee Joint Destruction in Patients with Rheumatoid Arthritis Treated with Tumour Necrosis Factor Inhibitors

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.220-220

2015

Volltextzugriff (PDF)

AB0377 Differences in Baseline Predictive Factors for Remission at 52 Weeks by Concomitant MTX Use during Tocilizumab Treatment Using Propensity Score Matched Groups

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1033-1033

2016

Volltextzugriff (PDF)

SAT0069 The Validation about The Measurement of Joint Space Distance by Using Super Resolution Image and Curve Fitting Methods

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.689-690

2016

Volltextzugriff (PDF)

AB0334 Clinical Efficacy of Certolizumab Pegol Therapy in Patients with Japanese Active Rheumatoid Arthritis 52 Week Result ∼A Multicenter Registry Study

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1015-1016

2016

Volltextzugriff (PDF)

The diagnostic ability of plasma Procalcitonin levels in Gram positive bacteremia

Journal of infection and public health, 2020-02, Vol.13 (2), p.335-336

2020

Volltextzugriff (PDF)

AB0485 Predictive Factors for Achievement of Low Disease Activity or Remission at 52 Weeks in Switching from TNF Inhibitors to Abatacept with Background of low Dose or no Methotrexate: A Multicenter Observational Cohort Study in Japan

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1059-1060

2015

Volltextzugriff (PDF)

THU0115 Importance of Both Disease Activity at 12 Weeks and Clinical Response up to 12 Weeks to Predict Achievement of Low Disease Activity at 52 Weeks During Abatacept Treatment in Biologics-Switching Patients with Rheumatoid Arthritis: A Multicenter Observational Cohort Study in Japan

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.235-236

2015

Volltextzugriff (PDF)

Magnetohydrodynamic Simulations of the Formation of Cold Fronts in Clusters of Galaxies Including Heat Conduction

The Astrophysical journal, 2004-05, Vol.606 (2), p.L105-L108

2004

Volltextzugriff (PDF)

AB0443 Influence of the Reason for Discontinuation of Previous TNF Antagonists on the Retention of Tocilizumab

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.954-955

2014

Volltextzugriff (PDF)

Small-cell lung cancer with epidermal growth factor receptor mutation: Case report and review of literature

Indian journal of cancer, 2014-07, Vol.51 (3), p.384

2014

Volltextzugriff (PDF)

Vitreous levels of vasohibin-1 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy

Diabetologia, 2009-02, Vol.52 (2), p.359-361

2009

Volltextzugriff (PDF)

Structural basis for recognition of cognate tRNA by tyrosyl-tRNA synthetase from three kingdoms

Nucleic acids research, 2007-07, Vol.35 (13), p.4289

2007

Volltextzugriff (PDF)

SAT0139 Importance of Concomitant MTX Use During Treatment with Tocilizumab in Patients with Rheumatoid Arthritis

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A628-A629

2013

Volltextzugriff (PDF)

Roles of induced expression of MAPK phosphatase-2 in tumor development in RET-MEN2A transgenic mice

Oncogene, 2008-09, Vol.27 (43), p.5684-5695

2008

Volltextzugriff (PDF)

AB0338 Evaluation of tocilizumab treatment continuation rate stratified by time of start of administration

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A890-A891

2013

Volltextzugriff (PDF)

AB0564 Continuation and remission rates of tocilizumab treatment based on improvement in patient global assessment: 2-year study based on the tsurumai biologics communication registry

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.670-670

2013

Volltextzugriff (PDF)

SAT0143 Analysis of Patients Who Obtained Remission by Disease Activity Score After Tocilizumab Treatment But Still had Low Disease Activity by Clinical Disease Activity Index, and Examination of Points for Treatment Intensification

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A630-A630

2013

Volltextzugriff (PDF)

AB0590 Rates of treatment continuation and remission in 97 patients with high c-reactive protein receiving tocilizumab: 2-year study based on the tsurumai biologics communication registry

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.672-672

2013

Volltextzugriff (PDF)

Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations

Molecular and Cellular Biology, 1995-03, Vol.15 (3), p.1613-1619

1995

Volltextzugriff (PDF)

1 – 25 von 1.854

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.333)
Mit Volltextzugriff
(1.532)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(980)
Life Sciences & Biomedicine
(648)
Humans
(599)
Male
(430)
Female
(341)
Biological And Medical Sciences
(337)
Animals
(279)
Middle Aged
(256)
Adult
(252)
Medical Sciences
(238)
Physical Sciences
(238)
Technology
(170)
Aged
(167)
Physics
(167)
Mice
(126)
Fundamental And Applied Biological Sciences. Psychology
(119)
Exact Sciences And Technology
(107)
Adolescent
(94)
Biochemistry & Molecular Biology
(87)
Rats
(86)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

A Case of Severe Pneumocystis Pneumonia in an HIV-Negative Patient Successfully Treated with Oral Atovaquone

Three-dimensional Magnetohydrodynamic Simulations of Cold Fronts in Magnetically Turbulent ICM

Arginine vasopressin neuronal loss results from autophagy-associated cell death in a mouse model for familial neurohypophysial diabetes insipidus

AB0476 Influence of the Reason for Discontinuation of Previous TNF Antagonists on the Retention of Tocilizumab

AB1181 The Impact of Physical Function on Patient Global Assessment in Rheumatoid Arthritis

AB0466 The Outcome of Tocilizumab Treatment with Achievement of Glucocorticoids Withdrawal Against Rheumatoid Arthritis for 24 Months from TBC Registry

THU0078 Effects of Concomitant Methotrexate on the Long-Term Outcome of Knee Joint Destruction in Patients with Rheumatoid Arthritis Treated with Tumour Necrosis Factor Inhibitors

AB0377 Differences in Baseline Predictive Factors for Remission at 52 Weeks by Concomitant MTX Use during Tocilizumab Treatment Using Propensity Score Matched Groups

SAT0069 The Validation about The Measurement of Joint Space Distance by Using Super Resolution Image and Curve Fitting Methods

AB0334 Clinical Efficacy of Certolizumab Pegol Therapy in Patients with Japanese Active Rheumatoid Arthritis 52 Week Result ∼A Multicenter Registry Study

The diagnostic ability of plasma Procalcitonin levels in Gram positive bacteremia

AB0485 Predictive Factors for Achievement of Low Disease Activity or Remission at 52 Weeks in Switching from TNF Inhibitors to Abatacept with Background of low Dose or no Methotrexate: A Multicenter Observational Cohort Study in Japan

THU0115 Importance of Both Disease Activity at 12 Weeks and Clinical Response up to 12 Weeks to Predict Achievement of Low Disease Activity at 52 Weeks During Abatacept Treatment in Biologics-Switching Patients with Rheumatoid Arthritis: A Multicenter Observational Cohort Study in Japan

Magnetohydrodynamic Simulations of the Formation of Cold Fronts in Clusters of Galaxies Including Heat Conduction

AB0443 Influence of the Reason for Discontinuation of Previous TNF Antagonists on the Retention of Tocilizumab

Small-cell lung cancer with epidermal growth factor receptor mutation: Case report and review of literature

Vitreous levels of vasohibin-1 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy

Structural basis for recognition of cognate tRNA by tyrosyl-tRNA synthetase from three kingdoms

SAT0139 Importance of Concomitant MTX Use During Treatment with Tocilizumab in Patients with Rheumatoid Arthritis

Roles of induced expression of MAPK phosphatase-2 in tumor development in RET-MEN2A transgenic mice

AB0338 Evaluation of tocilizumab treatment continuation rate stratified by time of start of administration

AB0564 Continuation and remission rates of tocilizumab treatment based on improvement in patient global assessment: 2-year study based on the tsurumai biologics communication registry

SAT0143 Analysis of Patients Who Obtained Remission by Disease Activity Score After Tocilizumab Treatment But Still had Low Disease Activity by Clinical Disease Activity Index, and Examination of Points for Treatment Intensification

AB0590 Rates of treatment continuation and remission in 97 patients with high c-reactive protein receiving tocilizumab: 2-year study based on the tsurumai biologics communication registry

Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations

Suchergebnisse filtern